Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a

S100B belongs to a family of calcium-binding proteins implicated in intracellular and extracellular regulatory activities. This study of serum S100B in primary progressive multiple sclerosis (PPMS) is based on data obtained from a randomized, controlled trial of Interferon β-1a in subjects with PPMS...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lim, Ee Tuan, Petzold, Axel, Leary, Siobhan M, Altmann, Daniel R, Keir, Geoff, Thompson, Ed J, Miller, David H, Thompson, Alan J, Giovannoni, Gavin
Format:	Artigo
Language:	Inglês
Published:	BioMed Central 2004
Subjects:	Research
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC524502/ https://ncbi.nlm.nih.gov/pubmed/15482599 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-5751-3-4
Tags:	Add Tag No Tags, Be the first to tag this record!

Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1a

Similar Items